Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 3
1985 1
1986 3
1987 2
1988 2
1989 2
1990 1
1991 2
1992 1
1995 1
1997 3
1998 4
2001 1
2002 3
2003 1
2004 2
2005 3
2006 1
2007 3
2008 1
2010 2
2011 3
2012 4
2013 6
2014 8
2015 7
2016 4
2017 7
2018 15
2019 4
2020 4
2021 6
2022 4
2023 4
2024 2
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
[NAVIGATOR trial (nateglinide)].
Tsujii S. Tsujii S. Nihon Rinsho. 2005 Feb;63 Suppl 2:483-7. Nihon Rinsho. 2005. PMID: 15779426 Review. Japanese. No abstract available.
Association Between Baseline Diabetes Therapy-Related Quality of Life (DTR-QOL) and Subsequent Risk of All-Cause Mortality: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT 26]).
Nishioka Y, Hayashino Y, Kurosawa K, Takano K, Matsunaga S, Okamura S, Tsujii S, Ishii H; Diabetes Distress and Care Registry at Tenri Study Group. Nishioka Y, et al. Among authors: tsujii s. Diabetes Ther. 2025 Aug;16(8):1633-1648. doi: 10.1007/s13300-025-01755-2. Epub 2025 Jun 10. Diabetes Ther. 2025. PMID: 40493295 Free PMC article.
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.
Nishigaki T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hara H, Sugase T, Otsuru T, Saito Y, Tsujii S, Nomura T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Nakajima K, Eguchi H, Yamasaki M, Mori M, Doki Y, Naka T. Nishigaki T, et al. Among authors: tsujii s. Br J Cancer. 2020 Apr;122(9):1333-1341. doi: 10.1038/s41416-020-0781-2. Epub 2020 Mar 10. Br J Cancer. 2020. PMID: 32152502 Free PMC article.
Association between physical activity and kidney function decline in patients with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 11]).
Okamura S, Niihata K, Nishiwaki H, Tsujii S, Ishii H, Hayashino Y, Kurita N; Diabetes Distress and Care Registry at Tenri Study Group. Okamura S, et al. Among authors: tsujii s. J Nephrol. 2023 Dec;36(9):2657-2660. doi: 10.1007/s40620-023-01691-z. Epub 2023 Jun 29. J Nephrol. 2023. PMID: 37382876 No abstract available.
Production of insulin antibody associated with relapsed hodgkin's lymphoma.
Ikeda M, Fujimura M, Kurosawa K, Tsugawa S, Sakuramachi Y, Takano K, Okamura S, Kitatani M, Iioka F, Tsujii S, Hayashino Y. Ikeda M, et al. Among authors: tsujii s. Diabetol Int. 2021 Oct 16;13(2):456-460. doi: 10.1007/s13340-021-00550-1. eCollection 2022 Apr. Diabetol Int. 2021. PMID: 35463857 Free PMC article.
Association between urinary C-megalin levels and progressive kidney dysfunction: a cohort study based on the diabetes distress and care registry at Tenri (DDCRT 24).
Niihata K, Nishiwaki H, Kinoshita M, Kurosawa K, Sakuramachi Y, Matsunaga S, Okamura S, Tsujii S, Hayashino Y, Kurita N; Diabetes Distress and Care Registry at Tenri Study Group. Niihata K, et al. Among authors: tsujii s. Acta Diabetol. 2023 Dec;60(12):1643-1650. doi: 10.1007/s00592-023-02144-6. Epub 2023 Jul 13. Acta Diabetol. 2023. PMID: 37439857
Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma.
Yokota K, Serada S, Tsujii S, Toya K, Takahashi T, Matsunaga T, Fujimoto M, Uemura S, Namikawa T, Murakami I, Kobayashi S, Eguchi H, Doki Y, Hanazaki K, Naka T. Yokota K, et al. Among authors: tsujii s. Mol Cancer Ther. 2021 Sep;20(9):1713-1722. doi: 10.1158/1535-7163.MCT-21-0015. Epub 2021 Jun 17. Mol Cancer Ther. 2021. PMID: 34224365
106 results